Position in KOD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$8,765,884
-$199,405 QoQ
Shares Held
229,955
-28.3% QoQ
Ownership
0.367%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KOD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026D. E. Shaw & Co., Inc. holds $4,371,472,260 across 180 Biotechnology names. KOD ranks #66 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
5,625,825 | $919,934,903 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,059,062 | $350,411,843 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
2,545,486 | $189,027,789 | |
| 4 | PCVX |
Vaxcyte, Inc.
|
2,865,318 | $166,503,628 | |
| 5 | EXEL |
Exelixis, Inc.
|
3,603,063 | $154,535,371 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
1,868,708 | $120,774,597 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
1,640,381 | $111,759,157 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
248,960 | $111,170,598 |
All Filings in KOD
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,765,884 | 229,955 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $8,965,289 | 320,647 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $7,495,102 | 457,856 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $2,244,075 | 601,629 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,159,273 | 768,425 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $8,478,155 | 852,076 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,397,963 | 918,760 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,221,106 | 945,152 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $5,494,858 | 1,044,650 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $3,675,277 | 1,208,973 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,793,039 | 996,133 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $6,822,008 | 988,697 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $6,706,539 | 1,081,700 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $8,343,203 | 1,165,252 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $7,624,433 | 985,069 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $7,514,451 | 983,567 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $7,703,201 | 997,824 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $269,346 | 3,177 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,006,926 | 10,491 | Shares | Defined | 2021-11-15 | |
| 2021-03-31 | $1,291,625 | 11,391 | Shares | Defined | 2021-05-17 | |
| 2020-09-30 | $1,009,826 | 17,055 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $1,036,127 | 19,145 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $1,122,475 | 23,532 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||